Price Targets: Developments for Stellantis, Thales, and Others
This Friday, July 10, several analysts are adjusting their stances on industrial, technology, and health sector stocks. Stellantis, Thales, and TFF Group face target cuts, while X-Fab, ArcelorMittal, and Coface see their targets raised.
Above Their Target: Key Highlights
Above their target: 4 values · Covered values: 61
Values above their target: MICHELIN (-5.1%) · NN GROUP (-4.2%) · AGEAS (-3.5%) · Coca-ColaEuropacif (-2.9%)
Largest gaps between target and current price:
CSG — target 30.75 euros — gap: +127.6%
CAPGEMINI — target 150.00 euros — gap: +68.5%
PROSUS — target 65.96 euros — gap: +66.2%
EXOR NV — target 109.00 euros — gap: +61.2%
ADYEN — target 1,300.00 euros — gap: +55.8%
Stellantis faces a double setback: JP Morgan downgrades from 'overweight' to 'neutral' and reduces the target from 10 to 6 euros; CIC Market Solutions also downgrades from 'buy' to 'hold' and cuts the target from 9 to 5.50 euros. Three analysts had already lowered their targets in the past 10 days, including one on July 9.
Thales: UBS maintains its 'buy' recommendation but reduces the target from 390 to 330 euros. An analyst had also lowered the target on July 9. The median of targets stands at 290 euros — gap between targets / price: +27.87%.
Initiating and Adjusting Coverage
TFF Group sees TP Icap Midcap lower its target from 18.50 to 16 euros, with a 'hold' recommendation. Two analysts had already lowered their targets in the past 10 days, including one on July 9.
Two brokers initiate coverage on Ekinops: TP Icap Midcap sets a target of 3 euros with a 'buy' recommendation, while Portzamparc targets 3.10 euros with a 'strengthen' recommendation.
Kaufman et Broad: Invest Securities starts tracking with a 'buy' recommendation and a target of 34 euros. However, an analyst had lowered the target on July 9.
ArcelorMittal receives mixed reviews: JP Morgan initiates with a 'neutral' recommendation and a target of 57 euros, while Goldman Sachs raises its target from 44 to 46 euros, maintaining a 'neutral' stance. Two analysts had already raised their targets in the past 10 days, including one on July 8.
Significant Target Adjustments and Recommendations
Coface sees its target raised from 20.90 to 22.50 euros by Berenberg, confirming its 'buy' recommendation.
Capgemini experiences a significant cut from Citi, which reduces the target from 160 to 130 euros. An analyst had also lowered the target on July 9. The consensus median stands at 150 euros, gap between targets / price: +68.54%.
BioMérieux: a dual movement with Oddo BHF lowering the target from 110 to 84 euros ('outperform'), while CIC Market Solutions initiates tracking at 100 euros ('buy'). An analyst had already lowered the target on July 7.
